Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data

References

• Ahad, A., Ganai, A. A., Mujeeb, M., and Siddiqui, W. A. (2014). Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy. Chem. Biol. Interact. 219:64–75.
   PubMed Web of Science ®Google Scholar
• Ahmed, N. (2005). Advanced glycation end products: role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67:3–21.
   PubMed Web of Science ®Google Scholar
• Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., James, W. P., Loria, C. M., and Smith, S. C. Jr.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Aldini, G., Maffei Facino, R., Beretta, G., and Carini M. (2005). Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. Biofactors 24:77–87.
   PubMed Web of Science ®Google Scholar
• Almeida, J. C., Zelmanovitz, T., Vaz, J. S., Steemburgo, T., Perassolo, M. S., Gross, J. L., and Azevedo, M. J. (2008). Sources of protein and polyunsaturated fatty acids of the diet and microalbuminuria in type 2 diabetes mellitus. J. Am. Coll. Nutr. 27:528–537.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. (2015). Standards of medical care in diabetes. Diabetes Care 38:S49–S66.
   PubMed Web of Science ®Google Scholar
• Bahadoran, Z., Mirmiran, P., and Azizi, F. (2013). Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications. J. Med. Food 16:375–382.
   PubMed Web of Science ®Google Scholar
• Bonora, E. (2006). The metabolic syndrome and cardiovascular disease. Ann. Med. 38:64–80.
   PubMed Web of Science ®Google Scholar
• Bonora, E., and Targher, G. (2012). Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 9:372–381.
   PubMed Web of Science ®Google Scholar
• Briffa, J. F., McAinch, A. J., Poronnik, P., and Hryciw, D. H. (2013). Adipokines as a link between obesity and chronic kidney disease. Am. J. Physiol. Renal Physiol. 305:F1629–F1636.
   PubMed Web of Science ®Google Scholar
• Cai, W., Uribarri, J., Zhu, L., Chen, X., Swamy, S., Zhao, Z., Grosjean, F., Simonaro, C., Kuchel, G. A., Schnaider-Beeri, M., Woodward, M., Striker, G. E., and Vlassara, H. (2014). Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc. Natl. Acad. Sci. USA 111:4940–4945.
   PubMed Web of Science ®Google Scholar
• D'Agati, V. D., Chagnac, A., de Vries, A. P., Levi, M., Porrini, E., Herman-Edelstein, M., and Praga, M. (2016). Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat. Rev. Nephrol. 12:453–471.
   PubMed Web of Science ®Google Scholar
• De Caterina, R., Madonna, R., Bertolotto, A., and Schmidt, E. B. (2007). n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care 30:1012–1026.
   PubMed Web of Science ®Google Scholar
• Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., and Baynes, J. W. (2002). Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int. 61:939–950.
   PubMed Web of Science ®Google Scholar
• Dussol, B., Iovanna, C., Raccah, D., Darmon, P., Morange, S., Vague, P., Vialettes, B., Olivier, C., Loundoun, A., and Berland, Y. (2005). A randomized trial of low-protein diet in type 1 and type 2 diabetes mellitus patients with incipient and overt nephropathy. J. Ren. Nutr. 15:398–406.
   PubMed Web of Science ®Google Scholar
• Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., Lamuela-Raventos, R. M., Serra-Majem, L., Pintó, X., Basora, J., Muñoz, M. A., Sorlí, J. V., Martínez, J. A., and Martínez-González, M. A.; PREDIMED Study Investigators (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 368:1279–1290.
   PubMed Web of Science ®Google Scholar
• Fanti, P., Asmis, R., Stephenson, T. J., Sawaya, B. P., and Franke, A. A. (2006). Positive effect of dietary soy in ESRD patients with systemic inflammation: correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol. Dial. Transplant. 21:2239–2246.
   PubMed Web of Science ®Google Scholar
• Ferraro, P. M., Lupo, A., Yabarek, T., Graziani, M. S., Bonfante, L., Abaterusso, C., and Gambaro, G.; Incipe Study Group (2011). Metabolic syndrome, cardiovascular disease, and risk for chronic kidney disease in an Italian cohort: analysis of the INCIPE study. Metab. Syndr. Relat. Disord. 9:381–388.
   PubMed Web of Science ®Google Scholar
• Franz, M. J., and Wheeler, M. L. (2003). Nutrition therapy for diabetic nephropathy. Curr. Diab. Rep. 3:412–417.
   PubMedGoogle Scholar
• Goldin, A., Beckman, J. A., Schmidt, A. M., and Creager, M. A. (2006). Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597–605.
   PubMed Web of Science ®Google Scholar
• Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., and Zelmanovitz, T. (2005). Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164–176.
   PubMed Web of Science ®Google Scholar
• Gross, J. L., Zelmanovitz, T., Moulin, C. C., De Mello, V., Perassolo, M., Leitão, C., Hoefel, A., Paggi, A., and Azevedo, M. J. (2002). Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial. Diabetes Care 25:645–651.
   PubMed Web of Science ®Google Scholar
• Hansen, H. P., Tauber-Lassen, E., Jensen, B. R., and Parving, H. H. (2002). Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 62:220–228.
   PubMed Web of Science ®Google Scholar
• Janssen, B., Hohenadel, D., Brinkkoetter, P., Peters, V., Rind, N., Fischer, C., Rychlik, I., Cerna, M., Romzova, M., de Heer, E., Baelde, H., Bakker, S. J., Zirie, M., Rondeau, E., Mathieson, P., Saleem, M. A., Meyer, J., Köppel, H., Sauerhoefer, S., Bartram, C. R., Nawroth, P., Hammes, H. P., Yard, B. A., Zschocke, J., and van der Woude, F. J. (2005). Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54:2320–2327.
   PubMed Web of Science ®Google Scholar
• Ji, H., Pesce, C., Zheng, W., Kim, J., Zhang, Y., Menini, S., Haywood, J. R., and Sandberg, K, (2005). Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am. J. Physiol. Heart Circ. Physiol. 288:H43–H47.
   PubMed Web of Science ®Google Scholar
• Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., and D'Agati, V. D. (2001). Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 59:1498–1509.
   PubMed Web of Science ®Google Scholar
• Kang, M. K., Li, J., Kim, J. L., Gong, J. H., Kwak, S. N., Park, J. H., Lee, J. Y., Lim, S. S., and Kang, Y. H. (2012). Purple corn anthocyanins inhibit diabetes-associated glomerular monocyte activation macrophage infiltration. Am. J. Physiol. Renal Physiol. 303:F1060–F1069.
   PubMed Web of Science ®Google Scholar
• KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease (2013). Kidney Int. Suppl. 3:19–62.
   Web of Science ®Google Scholar
• Kittiskulnam, P., Kanjanabuch, T., Tangmanjitjaroen, K., Chancharoenthana, W., Praditpornsilpa, K., and Eiam-Ong, S. (2014). The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin a nephropathy: a randomized controlled trial. J. Ren. Nutr. 24:200–207.
   PubMed Web of Science ®Google Scholar
• Kohen, R., Yamamoto, Y., Cundy, K. C., and Ames, B. N. (1988). Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc. Natl. Acad. Sci. USA 85:3175–3179.
   PubMed Web of Science ®Google Scholar
• Koschinsky, T., Ci-Jang, H., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., and Vlassara, H. (1997). Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. USA 94:6474–6479.
   PubMed Web of Science ®Google Scholar
• Kozlowska, L., Rydzewski, A., Fiderkiewicz, B., Wasinska-Krawczyk, A., Grzechnik, A., and Rosolowska-Huszcz, D. (2010). Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy. J. Ren. Nutr. 20:255–262.
   PubMed Web of Science ®Google Scholar
• Ladhani, M., Craig, J. C., Irving, M., Clayton, P. A. and Wong, G. (2017). Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrol. Dial. Transplant. Vol. 32. May 4. pii: gfw075. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Levey, A. S., Adler, S., Caggiula, A. W., England, B. K., Greene, T., Hunsicker, L. G., Kusek, J. W., Rogers, N. L., and Teschan, P. E. (1996). Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study. Am. J. Kidney Dis. 27:652–663.
   PubMed Web of Science ®Google Scholar
• Lopez-Moreno, J., Quintana-Navarro, G. M., Delgado-Lista, J., Garcia-Rios, A., Delgado-Casado, N., Camargo, A., Perez-Martinez, P., Striker, G. E., Tinahones, F. J., Perez-Jimenez, F., Lopez-Miranda, J., and Yubero-Serrano, E. M. (2016). Mediterranean diet reduces serum advanced glycation endproducts and increases antioxidant defenses in elderly adults: a randomized controlled trial. J. Am. Geriatr. Soc. 64:901–904.
   PubMed Web of Science ®Google Scholar
• Luk, A. O., So, W. Y., Ma, R. C., Kong, A. P., Ozaki, R., Ng, V. S., Yu, L. W., Lau, W. W., Yang, X., Chow, F. C., Chan, J. C., and Tong, P. C. (2008). Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 31:2357–2361.
   PubMed Web of Science ®Google Scholar
• Maric, C., and Hall, J. E. (2011). Obesity, metabolic syndrome and diabetic nephropathy. Contrib. Nephrol. 170:28–35.
   PubMed Web of Science ®Google Scholar
• Melhem, M. F., Craven, P. A., Liachenko, J., and De Rubertis, F. R. (2002). Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J. Am. Soc. Nephrol. 13:108–116.
   PubMed Web of Science ®Google Scholar
• Menini, S., Iacobini, C., Ricci, C., Blasetti Fantauzzi, C., and Pugliese, G. (2015). Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice. Diabetologia 58:845–853.
   PubMed Web of Science ®Google Scholar
• Menini, S., Iacobini, C., Ricci, C., Oddi, G., Pesce, C., Pugliese, F., Block, K., Abbound, H. E., Giorgio, M., Migliaccio, E., Pelicci, P. G., and Pugliese, G. (2007). Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Diabetologia 50:1997–2007.
   PubMed Web of Science ®Google Scholar
• Mogensen, C. E. (1999) Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42:263–285
   PubMed Web of Science ®Google Scholar
• Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., and Lachin, J.; Epidemiology of Diabetes Interventions and Complications Study Group (2010) Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 33:1536–1543
   PubMed Web of Science ®Google Scholar
• Mollsten, A. V., Dahlquist, G. G., Stattin, E. L., and Rudberg, S. (2001). Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type-1 diabetic patients. Diabetes Care 24:805–810.
   PubMed Web of Science ®Google Scholar
• Morcos, M., Borcea, V., Isermann, B., Gehrke, S., Ehret, T., Henkels, M., Schiekofer, S., Hofmann, M., Amiral, J., Tritschler, H., Ziegler, R., Wahl, P., and Nawroth, P. P. (2001). Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res. Clin. Pract. 52:175–183.
   PubMed Web of Science ®Google Scholar
• Nakamura, H., Ito, S., Ebe, N., and Shibata, A. (1993). Renal effects of different types of protein in healthy volunteer subjects and diabetic patients. Diabetes Care 16:1071–1075.
   PubMed Web of Science ®Google Scholar
• Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I., and Brownlee, M. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790.
   PubMed Web of Science ®Google Scholar
• Noce, A., Vidiri, M. F., Marrone, G., Moriconi, E., Bocedi, A., Capria, A., Rovella, V., Ricci, G., De Lorenzo, A., and Di Daniele, N. (2016). Is low-protein diet a possible risk factor of malnutrition in chronic kidney disease patients? Cell Death Discov. 2:16026.
   PubMedGoogle Scholar
• Noori, N., Tabibi, H., Hosseinpanah, F., Hedayati, M. and Nafar, M. (2013). Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy. Int. J. Vitam. Nutr. Res. 83:77–85.
   PubMed Web of Science ®Google Scholar
• Otoda, T., Kanasaki, K., and Koya, D. (2014). Low-protein diet for diabetic nephropathy. Curr. Diab. Rep. 14:523.
   PubMed Web of Science ®Google Scholar
• Packer, L., Kraemer, K., and Rinbach, G. (2001). Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17:888–895.
   PubMed Web of Science ®Google Scholar
• Palmer, S. C., Mavridis, D., Navarese, E., Craig, J. C., Tonelli, M., Salanti, G., Wiebe, N., Ruospo, M., Wheeler, D. C., and Strippoli, G. F. (2015). Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet 385:2047–2056.
   PubMed Web of Science ®Google Scholar
• Pan, Y., Guo, L. L., and Jin, H. M. (2008). Low-protein diet for diabetic nephropathy: a metanalysis of randomized controlled trials. Am. J. Clin. Nutr. 88:660–666.
   PubMed Web of Science ®Google Scholar
• Pedrini, M. T., Levey, A. S., Lau, J., Chalmers, T. C., and Wang, P. H. (1996). The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann. Int. Med. 124:627–632.
   PubMed Web of Science ®Google Scholar
• Perkovic, V., Heerspink, H. L., Chalmers, J., Woodward, M., Jun, M., Li, Q., MacMahon, S., Cooper, M. E., Hamet, P., Marre, M., Mogensen, C. E., Poulter, N., Mancia, G., Cass, A., Patel, A., and Zoungas, S.; ADVANCE Collaborative Group (2013). Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int. 83:517–523.
   PubMed Web of Science ®Google Scholar
• Pijls, L. T., de Vries, H., van Eijk, J. T., and Donker, A. J. (2002). Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur. J. Clin. Nutr. 56:1200–1207.
   PubMed Web of Science ®Google Scholar
• Praga, M., Hernandez, E., Andres, A., Leon, M., Ruilope, L. M., and Rodicio, J. L. (1995). Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 70:35–41.
   PubMed Web of Science ®Google Scholar
• Pugliese, G. (2014). Updating the natural history of diabetic nephropathy. Acta Diabetol. 51:905–915.
   PubMed Web of Science ®Google Scholar
• Reed, L. J. (2001). A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes. J. Biol. Chem. 276:38329–38336.
   PubMed Web of Science ®Google Scholar
• Rérat, A., Calmes, R., Vaissade, P., and Finot, P. A. (2002). Nutritional and metabolic consequences of the early Maillard reaction of heat treated milk in the pig. Significance for man. Eur. J. Nutr. 41:1–11.
   PubMed Web of Science ®Google Scholar
• Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., and Holman, R. R.; UKPDS Study Group (2006) Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55:1832–1839.
   PubMed Web of Science ®Google Scholar
• Riedl, E., Koeppel, H., Brinkkoetter, P., Sternik, P., Steinbeisser, H., Sauerhoefer, S., Janssen, B., van der Woude, F. J., and Yard, B. A. (2007). A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells. Diabetes 56:2410–2413.
   PubMed Web of Science ®Google Scholar
• Robertson, L. M., Waugh, N., and Robertson, A. (2007). Protein restriction for diabetic renal disease. Cochrane Database Syst. Rev. 4:CD002181.
   Google Scholar
• Rossing, P., Hansen, B. V., Nielsen, F. S., Myrup, B., Holmer, G., and Parving, H. H. (1996). Fish oil in diabetic nephropathy. Diabetes Care 19:1214–1219.
   PubMed Web of Science ®Google Scholar
• Saiki, A., Nagayama, D., Ohhira, M., Endoh, K., Ohtsuka, M., Koide, N., Oyama, T., Miyashita, Y., and Shirai, K. (2005). Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int. J. Obesity 29:1115–1120.
   Web of Science ®Google Scholar
• Silva, S., Bronze, M. R., Figueira, M. E., Siwy, J., Mischak, H., Combet, E., and Mullen, W. (2015). Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study. Am. J. Clin. Nutr. 101:44–54.
   PubMed Web of Science ®Google Scholar
• Sleight, P. (2000). The HOPE study (Heart Outcome Prevention Evaluation). J. Renin Angiotensin Aldosterone Syst. 1:18–20.
   PubMedGoogle Scholar
• Stinghen, A. E., Massy, Z. A., Vlassara, H., Striker, G. E., and Boullier, A. (2016). Uremic toxicity of advanced glycation end products in CKD. J. Am. Soc. Nephrol. 27:354–370.
   PubMed Web of Science ®Google Scholar
• Strippoli, G. F., Craig, M. C., Schena, F. P., and Craig, J. C. (2006). Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J. Am. Soc. Nephrol. 17:S153–S155.
   PubMed Web of Science ®Google Scholar
• Thorn, L. M., Forsblom, C., Wadén, J., Saraheimo, M., Tolonen, N., Hietala, K., and Groop, P. H. (2009). Finnish Diabetic Nephropathy (FinnDiane) Study Group (2009). Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 24 32:950–952.
   PubMed Web of Science ®Google Scholar
• Tozawa, M., Iseki, K., Iseki, C., Oshiro, S., Ikemiya, Y., and Takishita, S. (2002). Influence of smoking and obesity on the development of proteinuria. Kidney Int. 62:956–962.
   PubMed Web of Science ®Google Scholar
• UK Prospetive Diabetes Study (UKPDS) Group. (1988). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853.
   Google Scholar
• Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., and Vlassara, H. (2007). Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J. Gerontol. A Biol. Sci. Med. Sci. 62:427–433.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Cai, W., Sandu, O., Peppa, M., Goldberg, T., and Vlassara, H. (2005). Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann. N.Y. Acad. Sci. 1043:461–466.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Cai, W., Woodward, M., Tripp, E., Goldberg, L., Pyzik, R., Yee, K., Tansman, L., Chen, X., Mani, V., Fayad, Z. A., and Vlassara, H. (2015). Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity? J. Clin. Endocrinol. Metab. 100:1957–1966.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Woodruff, S., and Goodman, S. (2010). Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet. Assoc. 110:911–916, e12.
   Google Scholar
• Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., and Rayfield, E. J. (2002). Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc. Natl. Acad. Sci. USA 99:15596–15601.
   PubMed Web of Science ®Google Scholar
• Vlassara, H., Cai, W., Goodman, S., Pyzik, R., Yong, A., Chen, X., Zhu, L., Neade, T., Beeri, M., Silverman, J. M., Ferrucci, L., Tansman, L., Striker, G. E., and Uribarri, J. (2009). Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. J. Clin. Endocrinol. Metab. 94:4483–4491.
   PubMed Web of Science ®Google Scholar
• Vlassara, H., and Striker, G. E. (2011). AGE restriction in diabetes mellitus: a paradigm shift. Nat. Rev. Endocrinol. 7:526–539.
   PubMed Web of Science ®Google Scholar
• Wickman, C., and Kramer, H. (2013). Obesity and kidney disease: potential mechanisms. Semin. Nephrol. 33:14–22.
   PubMed Web of Science ®Google Scholar
• Williams, M. E., Bolton, W. K., Khalifah, R. G., Degenhardt, T. P., Schotzinger, R. J., and McGill, J. B. (2007). Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am. J. Nephrol. 27:605–614.
   PubMed Web of Science ®Google Scholar
• Yubero-Serrano, E. M., Woodward, M., Poretsky, L., Vlassara, H., and Striker, G. E.; AGE-less Study Group (2015). Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease. Clin. J. Am. Soc. Nephrol. 10:759–766.
   PubMed Web of Science ®Google Scholar
• Zeller, K., Whittaker, E., Sullivan, L., Raskin, P., and Jacobson, H. R. (1991). Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N. Engl. J. Med. 324:78–84.
   PubMed Web of Science ®Google Scholar
• Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M., and Vlassara, H. (2002). Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab. Res. Rev. 18:224–237.
   PubMed Web of Science ®Google Scholar
• Zheng, F., Zeng, Y. J., Plati, A. R., Elliot, S. J., Berho, M., Potier, M., Striker, L. J., and Striker, G. E. (2006). Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice. Kidney Int. 70:507–514.
   PubMed Web of Science ®Google Scholar